Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tobramycin ototoxicity: a second look.

R E Brummett, R T Brown

    Archives of Otolaryngology (Chicago, Ill. : 1960)
    |September 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Tobramycin temporarily impairs cochlear potential in guinea pigs, but only when blood pressure drops significantly. This effect is linked to hypotension, not direct tobramycin ototoxicity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Methylphenidate and hospitalized adolescents with conduct disorder: Dose effects on classroom behavior, academic performance, and impulsivity.

    Journal of youth and adolescence·2013
    Same author

    Implication of tyramine in the biosynthesis of morphinan alkaloids in Papaver.

    Planta·2013
    Same author

    TiO2 Photocatalysis for Indoor Air Applications: Effects of Humidity and Trace Contaminant Levels on the Oxidation Rates of Formaldehyde, Toluene, and 1,3-Butadiene.

    Environmental science & technology·2011
    Same author

    Perspective drawing by computer.

    Applied optics·2010
    Same author

    The unexpected preference for the fac-isomer with the tris(5-ester-substituted-2,2'-bipyridine) complexes of ruthenium(II).

    Inorganic chemistry·2004
    Same author

    Behavioral teratology/toxicology: how do we know what we know?

    Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists·2003
    Same journal

    Lidocaine in the treatment of Meniere's disease.

    Archives of otolaryngology (Chicago, Ill. : 1960)·1985
    Same journal

    Irradiation after neck dissection.

    Archives of otolaryngology (Chicago, Ill. : 1960)·1985
    Same journal

    Forehead lift.

    Archives of otolaryngology (Chicago, Ill. : 1960)·1985
    Same journal

    Laryngeal cyst of the thyroid cartilage.

    Archives of otolaryngology (Chicago, Ill. : 1960)·1985
    Same journal

    Metabolic facial paralysis in an infant.

    Archives of otolaryngology (Chicago, Ill. : 1960)·1985
    Same journal

    Effects of magnetic resonance imaging fields on stapedectomy prostheses.

    Archives of otolaryngology (Chicago, Ill. : 1960)·1985
    See all related articles

    Area of Science:

    • Ototoxicology
    • Pharmacology
    • Neuroscience

    Background:

    • Tobramycin is an aminoglycoside antibiotic with known nephrotoxic and ototoxic potential.
    • Previous studies suggest a link between aminoglycoside administration and auditory system dysfunction.

    Purpose of the Study:

    • To investigate the direct ototoxic effects of tobramycin on the cochlear potential in vivo.
    • To differentiate between direct tobramycin-induced ototoxicity and secondary effects related to hemodynamic changes.

    Main Methods:

    • Intravenous administration of tobramycin to guinea pigs.
    • Monitoring of alternating current cochlear potential.
    • Simultaneous measurement of systemic blood pressure.

    Main Results:

    Related Experiment Videos

    • Tobramycin administration resulted in temporary impairment of the alternating current cochlear potential.
    • This impairment was observed exclusively during periods of severe hypotension.
    • No evidence of permanent cochlear damage or ototoxicity was detected.

    Conclusions:

    • The observed cochlear effects are secondary to tobramycin-induced hypotension.
    • The data do not support direct ototoxicity of tobramycin at the tested dosage and conditions.
    • Hypotension is a critical factor to consider when evaluating tobramycin's effects on the auditory system.